About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Microbiome Research’s group seeks to investigate the role of the microbiota in health and disease. Its secondary objectives include developing molecular as well as bioinformatics tools to characterize the microbiome structure and function, discovering micro-biomarkers for diagnosis and prognosis, investigating how fecal microbiota transplantation could be used as a therapeutic strategy, and evaluating the impact of diet on the gut microbial ecosystem The Microbiome Lab is a multidisciplinary team, composed of molecular biologists, bioinformaticians, and physicians. The group tackles several clinical fields including inflammatory bowel diseases, diabetes, liver diseases, pre-term birth, and critical illness.
IP: Chaysavanh Manichanh Collaborators: Zaida Soler Luque, Judit Álvarez González Funding agency: Instituto de Salud Carlos III Funding: 119567 Reference: FI21/00262 Duration: 01/01/2022 - 31/12/2025
IP: Chaysavanh Manichanh Collaborators: Claudia Maria Herrera de Guise, Natalia Borruel Sainz, Francesc Casellas Jordá, Francisca Yañez Araya Funding agency: Instituto de Salud Carlos III Funding: 135520 Reference: PI20/00130 Duration: 01/01/2021 - 31/12/2024
PMID: 38017705 Journal: Gut Microbes Year: 2023 Reference: Gut Microbes. 2023 Dec;15(2):2287618. doi: 10.1080/19490976.2023.2287618. Epub 2023 Nov 28. Impact factor: Publication type: Paper in international publication Authors: Bougnoux, Marie-Elisabeth; Cole, Nathaniel; Consortium, Milieu Interieur; d'Enfert, Christophe; Delavy, Margot; Dubois, Florian; Duffy, Darragh; Le Chatelier, Emmanuelle; Manichanh, Chaysavanh; Patin, Etienne et al. DOI: 10.1080/19490976.2023.2287618
PMID: 38023553 Journal: Open Forum Infectious Diseases Year: 2023 Reference: Open Forum Infect Dis. 2023 Oct 31;10(11):ofad542. doi: 10.1093/ofid/ofad542. eCollection 2023 Nov. Impact factor: Publication type: Paper in international publication Authors: Arpa, Berta; Bernal, Enrique; Clotet, Bonaventura; Corral-Pujol, Marta; Cosovanu, Catalina; Curran, Adria; Domingo, Pere; Egia-Mendikute, Leire; Gutierrez, Felix; Imaz, Arkaitz et al. DOI: 10.1093/ofid/ofad542
PMID: 38029650 Journal: Respiratory Medicine and Research Year: 2023 Reference: Respir Med Res. 2023 Nov 4;84:101064. doi: 10.1016/j.resmer.2023.101064. Impact factor: Publication type: Paper in international publication Authors: Berastegui, Cristina; Berlana, David; Bougnoux, Marie-Elisabeth; Cardona-Pascual, Ignacio; Cole, Nathaniel; Consortium, Milieu Interieur; d'Enfert, Christophe; Delavy, Margot; Dubois, Florian; Duffy, Darragh et al. DOI: 10.1016/j.resmer.2023.101064
PMID: 38098063 Journal: Microbiome Year: 2023 Reference: Microbiome. 2023 Dec 14;11(1):275. doi: 10.1186/s40168-023-01693-w. Impact factor: Publication type: Paper in international publication Authors: Canalda-Baltrons, Aleix; d'Enfert, Christophe; Manichanh, Chaysavanh; Xie, Zixuan et al. DOI: 10.1186/s40168-023-01693-w
The study also linked improved microbiota diversity to better liver function.
This work sets the basis for future research aimed at a deeper understanding of the microbiota and the effect of nutrition.
These are the results of a study published in Nature Communications and led by the Vall d'Hebron Research Institute (VHIR), the University of Lleida (UdL) and the Biomedical Research Institute of Lleida (IRBLleida).
Check the current rates of the services offered by the Microbiome Research group
We are looking for approximately 1,000 volunteers who will have to answer a very simple questionnaire about their eating habits and provide a stool sample, 3 times over the course of a year.
